Cargando…
A case of T‐cell‐Epstein–Barr virus‐haemophagocytic lymphohistiocytosis and sustained remission following ruxolitinib therapy
OBJECTIVES: Epstein–Barr virus (EBV) is a common cause of secondary haemophagocytic lymphohistiocytosis (HLH). While B cells are reservoirs for EBV, infection within T cells and NK cells in this disease can be difficult to treat. METHODS: A 19‐year‐old female presented with a 6‐week history of coryz...
Autores principales: | Ali, Syed, Choo, Sharon, Hosking, Laine, Smith, Anthony, Hughes, Tiffany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368518/ https://www.ncbi.nlm.nih.gov/pubmed/37497193 http://dx.doi.org/10.1002/cti2.1459 |
Ejemplares similares
-
Bevacizumab/temozolomide/unspecified steroids: Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis: case report
Publicado: (2020) -
Case report: Ruxolitinib plus dexamethasone as first-line therapy in haemophagocytic lymphohistiocytosis
por: Zhao, Lin, et al.
Publicado: (2023) -
Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012) -
Haemophagocytic lymphohistiocytosis associated with fulminant hepatitis and multiorgan failure following primary Epstein–Barr virus and herpes simplex virus type 1 infection
por: Honsig, Claudia, et al.
Publicado: (2017) -
Novel mutations of STXBP2 and LYST associated with adult haemophagocytic lymphohistiocytosis with Epstein-Barr virus infection: a case report
por: Sheng, Lingshuang, et al.
Publicado: (2019)